Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Rheumatoid Arthritis
In brief
This study will provide efficacy and safety data of the secukinumab pre-filled syringe (PFS) for subcutaneous self-administration in patients with active rheumatoid arthritis who are intolerant to or have had an inadequate response to anti-TNF-α agents.
Key facts
- Study ID
- NCT01770379
- Run by
- Novartis Pharmaceuticals
- People needed
- 242
- Starts
- 2012-10-01
- Expected to finish
- 2015-05-01
- Last updated by the study team
- 2016-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Santa Monica, California, United States
- Novartis Investigative Site — Upland, California, United States
- Novartis Investigative Site — Miami, Florida, United States
- Novartis Investigative Site — Pembroke Pines, Florida, United States
- Novartis Investigative Site — Zephyrhills, Florida, United States
- Novartis Investigative Site — Cumberland, Maryland, United States
- Novartis Investigative Site — Edina, Minnesota, United States
- Novartis Investigative Site — Tupelo, Mississippi, United States
- Novartis Investigative Site — Lees Summit, Missouri, United States
- Novartis Investigative Site — St Louis, Missouri, United States
- Novartis Investigative Site — Reno, Nevada, United States
- Novartis Investigative Site — Albuquerque, New Mexico, United States
- Novartis Investigative Site — Zanesville, Ohio, United States
- Novartis Investigative Site — Oklahoma City, Oklahoma, United States
- Novartis Investigative Site — Oklahoma City, Oklahoma, United States
- Novartis Investigative Site — North Charleston, South Carolina, United States
- Novartis Investigative Site — Rapid City, South Dakota, United States
- Novartis Investigative Site — Jackson, Tennessee, United States
- Novartis Investigative Site — Nashville, Tennessee, United States
- Novartis Investigative Site — Amarillo, Texas, United States
- Novartis Investigative Site — Benbrook, Texas, United States
- Novartis Investigative Site — Houston, Texas, United States
- Novartis Investigative Site — Houston, Texas, United States
- Novartis Investigative Site — Mesquite, Texas, United States
- Novartis Investigative Site — Peoria, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.